Overview

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

Status:
Completed
Trial end date:
2018-08-21
Target enrollment:
Participant gender:
Summary
This is a non-randomized, 2-part, open-label, drug-drug interaction (DDI) study to evaluate the effect of concomitant administration of fluconazole or quinidine on the pharmacokinetics and safety of EDP-305 in healthy human volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Enanta Pharmaceuticals
Treatments:
Fluconazole
Quinidine
Quinidine gluconate